WENDY WEISS: Open Payments
NPI 1609867738 · PISMO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,344 in 90 payments from 23 companies in 2025. Trend: 2023 $1,705 · 2024 $1,522 · 2025 $2,344
Food & beverage: $2,344
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $316 |
| ABBVIE INC. | 18 | $261 |
| Novo Nordisk Inc | 7 | $254 |
| Amgen Inc. | 5 | $212 |
| Ardelyx, Inc. | 7 | $186 |
| PFIZER INC. | 10 | $174 |
| Lilly USA, LLC | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $111 |
| Radius Health, Inc. | 4 | $96 |
| GlaxoSmithKline, LLC. | 4 | $79 |
Products named: BREZTRI, EVENITY, IBSRELA, VRAYLAR, JARDIANCE, INGREZZA, Ozempic, Tymlos.
Industry payments across CA — which companies pay providers there.
